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Purpose: Coronary artery calcification (CAC) has been described in individuals 
with chronic kidney disease (CKD), and its presence is associated with an in-
creased risk of cardiovascular death. However, it is unclear whether there is an in-
dependent relationship between renal function and CAC. Therefore, we evaluated 
the association between renal function and CAC. Materials and Methods: We 
retrospectively reviewed 870 Korean patients who had undergone computed to-
mographic coronary angiography. The glomerular filtration rate (GFR) was esti-
mated using the Modification of Diet in Renal Disease study formula with an eth-
nic factor for the Korean population. The CKD stages were classified using 
estimated GFR (eGFR) and proteinuria. Results: The mean age of the participants 
was 56.8±11.8 years, and the mean eGFR was 89.4±16.5 mL/min/1.73 m2. Hyper-
tension and diabetes were noted in 41.5 and 17.0% of patients, respectively. There 
were 584 and 286 patients with no CAC and with CAC, respectively. After adjust-
ing for confounding variables, late stage CKD was associated with CAC [odds ra-
tio (OR) 2.80, 95% confidence interval (CI) 1.05-7.46]. However, early stage 
CKD was not associated with CAC (OR 1.61, 95% CI 0.92-2.82). Diabetes was 
an independent risk factor of CAC (OR 2.06, 95% CI 1.36-3.13). There was no 
significant association between proteinuria and CAC (OR 1.65, 95% CI 0.96-
2.85). Conclusion: CAC is related to late stage CKD in nondialyzed patients. 
These findings emphasize that individuals with CAC should be considered a high-
risk population for decreased renal function.
Key Words:    Chronic kidney disease, coronary artery calcification, proteinuria, re-
nal function 
INTRODUCTION
Cardiovascular disease (CVD) is a significant clinical problem and the most com-
mon cause of morbidity and mortality in patients with chronic kidney disease 
(CKD).1 As the glomerular filtration rate (GFR) decreases, the relative risk of mor-
tality from CVD increases.2 In patients with CKD, the rates of cardiovascular mor-Jae Hyun Chang, et al.
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sified using the eGFR and proteinuria data.14 Stage 1 or 2 
CKD was defined as proteinuria with eGFR ≥60 mL/min/ 
1.73 m2. Stage 3 or 4 CKD was defined as eGFR 15-60 
mL/min/1.73 m2.
We assessed CAC using a Somatom Definitions dual-
source CT scanner (Siemens Medical Systems, Forchheim, 
Germany), utilizing a calcium threshold of ≥130 Houn-
sfield units. As Agatston, et al.15 described, CAC score was 
determined by multiplying the area of each calcified lesion 
by a weighting factor corresponding to the peak pixel inten-
sity for each lesion. The sum of each lesion for all coronary 
arteries was used for analyses. All images were scored by a 
single radiologist. CAC was categorized as being either 
present (Agatston score >0) or absent.
The study protocol was approved by the local medical 
ethics committee.
　
Statistical analysis 
The results are reported as mean±SD or numbers (percent-
ages). Differences in baseline characteristics were com-
pared across CKD stages using an analysis of variance and 
the chi-square test or Fisher’s exact test for categorical vari-
ables, as appropriate. To identify the factors associated with 
each independent variable of CKD stage, diabetes and pro-
teinuria, all variables with p<0.10 were entered into the 
multivariate regression analysis. The covariate-adjusted 
odds ratios (OR) and their 95% confidence intervals (CI) 
according to CKD stage, diabetes and proteinuria were de-
rived in multiple logistic regression models for CAC. When 
the associations between the CAC score and various pa-
rameters were evaluated, the distribution of CAC scores 
was non-normal; subsequently, the analysis comparing 
CAC score and renal function was performed using log-
transformed [In (1+absolute CAC score)] CAC scores. In-
dependent factors associated with CAC were determined 
by multiple linear regression analysis. Values with p<0.05 
were considered statistically significant. The data analysis 
was conducted using SPSS software version 12.0 for Win-
dows (SPSS Inc., Chicago, IL, USA). 
 
RESULTS
 
The baseline characteristics of the study population are 
shown in Table 1. In total, 870 subjects were analyzed. The 
mean age of the participants was 56.8±11.8 years, and the 
mean eGFR was 89.4±16.5 mL/min/1.73 m2. There were 
bidity and mortality are higher than those in people with 
normal renal function and are well behind the rates expected 
based on traditional risk factors.3 Therefore, other factors are 
responsible for the excessive cardiovascular events in CKD.
Numerous mechanisms link CKD and CVD. Traditional 
and nontraditional risk factors, such as mineral metabolism 
abnormalities, are associated with coronary artery calcifica-
tion (CAC) in patients with coronary artery disease and 
CKD.4 Vascular calcification is a potential mechanism that 
explains the association between renal function and cardio-
vascular mortality. Vascular calcification is a severe vascu-
lar change that has been increasingly recognized as a signif-
icant predictor of cardiovascular morbidity and mortality. 
Some studies have shown that renal impairment is asso-
ciated with higher CAC scores in non-dialysis and dialysis 
patients,5-9 while in other studies the association between 
impaired renal function and CAC either was not significant 
or strongly attenuated after adjusting for cardiovascular risk 
factors.10,11 It is unclear whether there is an independent re-
lationship between renal function and CAC, as previous 
studies have produced conflicting results regarding this re-
lationship. Therefore, this study evaluated the association 
between renal function and CAC in nondialyzed patients.
MATERIALS AND METHODS
　　　
Study population
We retrospectively reviewed 870 consecutive Korean sub-
jects who had undergone multislice computed tomography 
(CT) coronary angiography at Gachon University Gil Hos-
pital from January 2008 to December 2009. Their medical 
records were reviewed to obtain demographic data, infor-
mation on the presence of traditional cardiac risk factors, 
blood pressure (BP), and laboratory results. Hypertension 
was defined as a systolic BP ≥140 mm Hg, a diastolic BP 
≥90 mm Hg, or current use of antihypertensive medication. 
Diabetes was defined as a fasting glucose ≥126 mg/dL or 
use of hypoglycemic medications. Body mass index (BMI) 
was calculated as weight in kilograms divided by height in 
meters squared. The estimated GFR (eGFR) was calculated 
from the serum creatinine level measured in closest prox-
imity to the multislice CT coronary angiography using the 
Modification of Diet in Renal Disease study formula with 
an ethnic factor for the Korean population.12,13 Proteinuria 
was defined as the presence of +1 or more proteinuria upon 
random-urine dipstick analysis. CKD stages were then clas-CAC & Renal Function in CKD
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stage 1 or 2 CKD and 70.0% with stage 3 or 4 CKD.
The relationship between CAC and CKD stages is shown 
in Table 2. After adjusting for confounding variables, in-
cluding age, gender, hypertension, and diabetes, CAC was 
associated with stage 3 or 4 CKD (OR 2.80, 95% CI 1.05-
7.46, p=0.039), but not with stage 1 or 2 CKD (OR 1.61, 
95% CI 0.92-2.82, p=0.099).
The association of CAC with diabetes is shown in Table 
3. Diabetics had CAC more frequently than non-diabetics 
(53.3% vs. 28.6%, p<0.001). After adjusting for confound-
ing variables, including age, gender, hypertension, eGFR, 
and proteinuria, diabetes was a risk factor for CAC (OR 
2.06, 95% CI 1.36-3.13, p<0.001).
The relationship between CAC and proteinuria is shown 
in Table 4. More subjects with proteinuria had CAC than 
those without proteinuria (49.4% vs. 31.0%, p=0.001). 
There was an association between proteinuria and CAC in 
the unadjusted analysis, while there was no significant asso-
ciation between proteinuria and CAC after adjusting for the 
confounding variables, including age, gender, hypertension, 
diabetes, and eGFR (OR 1.65, 95% CI 0.96-2.85, p=0.070).
The multiple linear regression analysis for independent 
factors associated with the log-transformed CAC score is 
shown in Table 5. Therein, CAC scores were correlated 
with age, male, hypertension, diabetes, eGFR <60 mL/
min/1.73 m2, and proteinuria.
584 patients with CAC and 286 without CAC. Compared 
with the subjects without CKD, the patients with CKD were 
older, had a higher CAC score as well as lower albumin, and 
more of these patients had a history of diabetes and hyperten-
sion. However, there was no significant difference in current 
smoking status, BMI, systolic BP, diastolic BP, calcium-
phosphorus (Ca×P) product, or total cholesterol among the 
three groups.
The distributions of CAC scores according to CKD stage 
in the total study population, in the nondiabetic and diabetic 
populations, and in the populations with and without pro-
teinuria are shown in Fig. 1. For the total population without 
CKD, the CAC scores were 0, 1-100, 101-400, and >400 in 
70.1, 17.6, 7.8, and 4.5%, respectively. The frequency of 
CAC was 1.5-fold higher among participants with stage 1 or 
2 CKD (46.8%) and was more than 2-fold higher among 
participants with stage 3 or 4 CKD (71.0%), compared to 
participants without CKD (29.9%). In the nondiabetic popu-
lation, CAC was detected in 26.2% of patients without 
CKD, 38.2% with stage 1 or 2 CKD, and 61.9% with stage 
3 or 4 CKD. Among the diabetics, CAC was noted in 47.5% 
of those without CKD, 68.2% with stage 1 or 2 CKD, and 
90.0% with stage 3 or 4 CKD. In the population without 
proteinuria, CAC was seen in 29.9% of the patients without 
CKD and 71.4% of those with stage 3 or 4 CKD. Of those 
with proteinuria, CAC was seen in 46.8% of those with 
Table 1. Baseline Characteristics of the Study Population 
Total (n=870)
Chronic kidney disease stages
No. (n=762) Stage 1 or 2 (n=77) Stage 3 or 4 (n=31) p value
Age (yrs)   56.8±11.8      56.0±11.5      59.9±12.6 68.5±9.0 <0.001
Male (%) 419 (48.2) 372 (48.8) 37 (48.1) 10 (32.3)   0.195
Current smoker (%) 140 (16.1) 129 (16.9) 7 (9.1)   4 (12.9)   0.283
Hypertension (%) 361 (41.5) 296 (38.8) 44 (57.1) 21 (67.7) <0.001
Diabetes (%) 150 (17.0) 118 (15.5) 22 (28.6) 10 (32.3)   0.001
Body mass index (kg/m
2) 25.1±3.5 25.0±3.4 25.8±4.0 25.7±4.1   0.163
Systolic BP (mm Hg) 128±18 128±18 130±19 129±20   0.401
Diastolic BP (mm Hg)   77±12   77±12   78±13   76±13   0.705
CAC score (AU)     92±337     62±227   201±475     567±1061 <0.001
eGFR (mL/min/1.73m
2)   89.4±16.5   91.1±14.9   88.3±16.0 52.1±8.7 <0.001
Albumin (g/dL)   4.4±0.3   4.4±0.3   4.3±0.4   4.1±0.5 <0.001
Ca (mg/dL)   9.0±0.5   9.0±0.5   8.9±0.5   9.0±0.4   0.225
P (mg/dL)   3.8±0.6   3.8±0.6   3.8±0.8   4.1±0.8   0.021
Ca×P product (mg
2/dL
2) 34.2±6.7 34.1±6.6 34.1±7.2 37.2±7.0   0.084
Total cholesterol (mg/dL) 192±40 193±40 189±40 191±45   0.895 
Triglyceride (mg/dL) 147±98 146±99 152±81 151±93   0.895
Proteinuria 87 (10.0) 0 (0) 77 (100) 10 (32.3) <0.001
BP, blood pressure; CAC, coronary artery calcification; eGFR, estimated glomerular filtration rate; Ca, calcium; P, phosphorus. 
Data are expressed as mean±SD or number (%). Jae Hyun Chang, et al.
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Fig. 1. Distribution of coronary artery calcification (CAC) scores according to chronic kidney disease (CKD) stage. (A) All patients, (B) 
stratified by the presence of diabetes, and (C) stratified by the presence of proteinuria.
Table 2. Association of Coronary Artery Calcification (CAC) with Chronic Kidney Disease (CKD) Stage 
No CKD Stage 1 or 2 CKD  Stage 3 or 4 CKD 
Participants with CAC [n/N (%)] 228/762 (29.9) 36/77 (46.7) 22/31 (71.0)
Unadjusted odds ratio (95% CI)  1.00 (reference) 2.06 (1.28-3.30)   5.73 (2.60-12.63)
Adjusted odds ratio (95% CI)*  1.00 (reference) 1.61 (0.92-2.82) 2.80 (1.05-7.46)
*Adjusted for age, gender, hypertension, and diabetes.
Table 3. Association of Coronary Artery Calcification (CAC) with Diabetes
No diabetes Diabetes p value
Participants with CAC [n/N (%)] 206/720 (28.6) 80/150 (53.3) <0.001
Unadjusted odds ratio (95% CI) 1.00  2.85 (1.99-4.08) <0.001
Adjusted odds ratio (95% CI)* 1.00 2.06 (1.36-3.13) <0.001
eGFR, estimated glomerular filtration rate.
*Adjusted for age, gender, hypertension, eGFR, and proteinuria.  
Table 4. Association of Coronary Artery Calcification (CAC) with Proteinuria 
No proteinuria Proteinuria p value
Participants with CAC [n/N (%)] 243/783 (31.0) 43/87 (49.4)   0.001
Unadjusted odds ratio (95% CI) 1.00  2.17 (1.39-3.39) <0.001
Adjusted odds ratio (95% CI)* 1.00 1.65 (0.96-2.85)   0.070
eGFR, estimated glomerular filtration rate.
*Adjusted for age, gender, hypertension, diabetes, and eGFR.CAC & Renal Function in CKD
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nondiabetic stratum.11 Two other studies reported positive 
relationships between CKD and CAC, yet both investiga-
tions studied individuals with diabetes exclusively.22,23 In-
creased CAC scores in CKD patients with diabetes may re-
flect end-organ damage caused by multiple metabolic 
derangements. Decreased GFR in diabetic patients may 
contribute to changes in the levels of calcium-regulating 
glycoproteins or cytokines, which can interact with hyper-
glycemia and accelerate the development or progression of 
atherosclerosis.11 Calcium precipitates in coronary athero-
sclerotic arteries by the glycoproteins found in bone forma-
tion.24 Decreased serum levels of extracellular calcium-reg-
ulatory proteins have been implicated as risk factors for 
excess vascular calcification in patients with CKD25,26 and 
may be operative in patients who have diabetes and a de-
creased GFR. However, the associations between CKD and 
CAC within these studies may have been confounded by a 
longer duration or increased severity of diabetes, rather 
than reflecting an independent association of kidney disease 
with calcification.
We observed that CAC scores were related to proteinuria 
and there was a likely association between proteinuria and 
the presence of CAC. There was an association between 
proteinuria and CAC in the unadjusted analysis, but the as-
sociation was not statistically significant after multivariate 
adjustment. Cho, et al.19 found significant differences in the 
prevalence of CAC scores >100 between stage 3 CKD with 
and without proteinuria. A recent study showed that micro-
albuminuria is associated with a greater incidence and de-
gree of progression of CAC in individuals free of coronary 
heart disease.27 Further longitudinal studies are needed to 
evaluate the relationship between CAC and proteinuria. 
Our study had several limitations. First, the study was 
retrospective; therefore, it was difficult to infer causality be-
tween CAC and renal function, and selection bias may have 
influenced the results. Second, we had no data on medica-
DISCUSSION
This study found that CAC was related to a moderately im-
paired renal function in nondialyzed patients. Renal func-
tion may play an important role in the prevalence and pro-
gression of CAC. It has been suggested that CAC starts 
early in the course of CKD and progresses with the deterio-
ration in renal function.16 In an animal study, calcification 
of the aorta and heart in rats with a 5/6 nephrectomy accel-
erated renal disease progression, and a reduction in the cal-
cification-related changes may have ameliorated the renal 
dysfunction associated with renal calcification. It is possible 
that calcification-related changes are related to a decrease in 
GFR and that calcification of the heart may be an indicator 
of calcification-related changes.17 However, previous epide-
miological studies found conflicting results regarding the 
relationship between renal function and CAC. Kramer, et 
al.11 evaluated 2660 participants with a median age of 49 
years in the Dallas Heart Study and observed a strong asso-
ciation between CKD and CAC among diabetic partici-
pants. By contrast, Fox, et al.10 evaluated 319 participants in 
the Framingham Heart Study, with a mean eGFR of 86 mL/
min/1.73 m2 and a mean age of 60 years, and observed an 
association between a lower eGFR and a higher prevalence 
of CAC in an unadjusted analysis, but the association was 
of marginal statistical significance after multivariate adjust-
ment for cardiovascular risk. Watanabe, et al.16 revealed that 
the prevalence of severe CAC increased gradually based on 
the progression of CKD, but the result was not significant. 
Ix, et al.18 showed that the higher burden of CAC is unlike-
ly to explain the association between mild to moderate kid-
ney dysfunction found among 6749 participants in the 
Multi-Ethnic Study of Atherosclerosis, with a mean GFR of 
79 mL/min/1.73 m2 and a mean age of 63 years. Cho, et 
al.19 found no significant association between a decrease in 
eGFR and a CAC score >100 after adjusting for proteinuria 
and other confounding factors. This discrepancy might be 
explained by differences in the characteristics of the study 
populations, such as age, renal function and comorbidity, as 
well as the use of different CAC criteria.
Diabetes is a strong risk factor for vascular calcification 
independent of renal function.20,21 The association between 
CKD and increased CAC score differs substantially with 
the presence of diabetes. In the Dallas Heart Study, a strong 
association was found between CKD and CAC among par-
ticipants with diabetes, but no association was found in the 
Table 5. Multiple Linear Regression Analysis for Indepen-
dent Factors Associated with Log-Transformed Coronary 
Artery Calcification Scores 
β p value
Age (yrs) 0.439 <0.001
Gender (male) 0.168 <0.001
Hypertension 0.071   0.019
Diabetes 0.090   0.003
eGFR <60 mL/min/1.73m
2 0.148 <0.001
Proteinuria 0.073   0.013
eGFR, estimated glomerular filtration rate.Jae Hyun Chang, et al.
Yonsei Med J   http://www.eymj.org   Volume 53   Number 4   July 2012 690
the Dallas Heart Study. J Am Soc Nephrol 2005;16:507-13.
12. Lee CS, Cha RH, Lim YH, Kim H, Song KH, Gu N, et al. Ethnic 
coefficients for glomerular filtration rate estimation by the Modifi-
cation of Diet in Renal Disease study equations in the Korean 
population. J Korean Med Sci 2010;25:1616-25. 
13. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A 
more accurate method to estimate glomerular filtration rate from 
serum creatinine: a new prediction equation. Modification of Diet 
in Renal Disease Study Group. Ann Intern Med 1999;130:461-70.
14. National Kidney Foundation. K/DOQI clinical practice guidelines 
for chronic kidney disease: evaluation, classification, and stratifi-
cation. Am J Kidney Dis 2002;39(2 Suppl 1):S1-266.
15. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M 
Jr, Detrano R. Quantification of coronary artery calcium using ul-
trafast computed tomography. J Am Coll Cardiol 1990;15:827-32.
16. Watanabe R, Lemos MM, Manfredi SR, Draibe SA, Canziani ME. 
Impact of cardiovascular calcification in nondialyzed patients after 
24 months of follow-up. Clin J Am Soc Nephrol 2010;5:189-94.
17. Kawata T, Nagano N, Obi M, Miyata S, Koyama C, Kobayashi N, 
et al. Cinacalcet suppresses calcification of the aorta and heart in 
uremic rats. Kidney Int 2008;74:1270-7.
18. Ix JH, Katz R, Kestenbaum B, Fried LF, Kramer H, Stehman-
Breen C, et al. Association of mild to moderate kidney dysfunction 
and coronary calcification. J Am Soc Nephrol 2008;19:579-85.
19. Cho I, Min HS, Chun EJ, Park SK, Choi Y, Blumenthal RS, et al. 
Coronary atherosclerosis detected by coronary CT angiography in 
asymptomatic subjects with early chronic kidney disease. Athero-
sclerosis 2010;208:406-11. 
20. Katz R, Wong ND, Kronmal R, Takasu J, Shavelle DM, Probst-
field JL, et al. Features of the metabolic syndrome and diabetes 
mellitus as predictors of aortic valve calcification in the Multi-
Ethnic Study of Atherosclerosis. Circulation 2006;113:2113-9.
21. Schurgin S, Rich S, Mazzone T. Increased prevalence of signifi-
cant coronary artery calcification in patients with diabetes. Diabe-
tes Care 2001;24:335-8.
22. Qunibi WY, Abouzahr F, Mizani MR, Nolan CR, Arya R, Hunt 
KJ. Cardiovascular calcification in Hispanic Americans (HA) with 
chronic kidney disease (CKD) due to type 2 diabetes. Kidney Int 
2005;68:271-7.
23. Mehrotra R, Budoff M, Hokanson JE, Ipp E, Takasu J, Adler S. 
Progression of coronary artery calcification in diabetics with and 
without chronic kidney disease. Kidney Int 2005;68:1258-66.
24. Wexler L, Brundage B, Crouse J, Detrano R, Fuster V, Maddahi J, 
et al. Coronary artery calcification: pathophysiology, epidemiolo-
gy, imaging methods, and clinical implications. A statement for 
health professionals from the American Heart Association. Writ-
ing Group. Circulation 1996;94:1175-92.
25. Ketteler M, Wanner C, Metzger T, Bongartz P, Westenfeld R, 
Gladziwa U, et al. Deficiencies of calcium-regulatory proteins in 
dialysis patients: a novel concept of cardiovascular calcification in 
uremia. Kidney Int Suppl 2003:S84-7.
26. Ketteler M, Bongartz P, Westenfeld R, Wildberger JE, Mahnken 
AH, Böhm R, et al. Association of low fetuin-A (AHSG) concen-
trations in serum with cardiovascular mortality in patients on dial-
ysis: a cross-sectional study. Lancet 2003;361:827-33.
27. DeFilippis AP, Kramer HJ, Katz R, Wong ND, Bertoni AG, Carr J, 
et al. Association between coronary artery calcification progres-
sion and microalbuminuria: the MESA study. JACC Cardiovasc 
Imaging 2010;3:595-604.
tion use, such as the use of phosphate binders or lipid-low-
ering agents.
In conclusion, CAC is related to late stage CKD in non-
dialyzed patients. Our findings emphasize that individuals 
with CAC should be considered a high-risk population for 
decreased renal function. This might help explain the in-
creased risk of cardiovascular disease in patients with CKD. 
Further exploration is clearly needed to evaluate the rela-
tionship between CAC and renal function.
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